According to sources familiar with the matter, Juul Labs Inc. has agreed to pay $1.7 billion to settle over 5,000 lawsuits brought by school districts, local governments, and individuals who claim that their e-cigarettes are more addictive than advertised.
According to sources, Bloomberg has reported that Juul Labs has agreed to pay $1.2 billion to settle around 10,000 lawsuits against the e-cigarette manufacturer, which are the primary cause of the youth vaping epidemic in the United States.
According to a report from the San Francisco Examiner, this e-cigarette manufacturer faces over 8,000 lawsuits brought by Juul users, including individuals and families, school districts, municipalities, and Native American tribes. This week's settlement resolves a large portion of these cases, which have been consolidated in a California federal court pending trial of several lead cases.
The Wall Street Journal reported that on December 6, Juul Labs settled over 5,000 lawsuits involving over 10,000 individual plaintiffs. The financial terms of the settlement were not disclosed.
In a press release, Juul Labs announced that it has reached a settlement with the plaintiffs of the federal multi-district litigation (MDL) and related "Juul Labs Product Cases" (JCCP), which were consolidated in the Northern District of California court. Juul Labs did not disclose any monetary figures.
The company stated, "These settlements represent an important step in strengthening Juul Labs' operations and ensuring the path forward for the company to fulfill its mission of keeping adult smokers away from combustible cigarettes while combating underage use.
According to Juul Labs, the global resolution covers over 5,000 cases brought against Juul Labs, its executives, and directors by approximately 10,000 plaintiffs.
According to a press release, over the past year, Juul Labs has reached settlements with 37 states and jurisdictions, and is still in discussions with other major stakeholders to resolve remaining litigation.
According to media reports, the amount involved in this transaction concerns the consolidation of cases centered around Northern California, and is more than three times the settlement amount reported in other state and local cases involving Juul Labs to date.
This deal resolves much of the legal uncertainty that had put the company on the brink of bankruptcy.
On December 6th, Juul announced that it has secured an investment to pay for settlement fees. The company has been in negotiations with two early investors to fund a relief plan that includes legal liabilities.
Juul CEO KC Crosthwaite has stated that the settlement resolves the majority of outstanding lawsuits against the company, including two high-profile trials set to begin early next year and four categories of entities: personal injury plaintiffs, Juul consumers, government school districts, and Native American tribes. Several lawsuits brought by state attorneys general are still ongoing.
As a pioneer in the electronic cigarette industry, Juul Labs went from dominating the American e-cigarette market to struggling for survival in a relatively short period of time.
2FIRSTS will continue to provide ongoing coverage of this topic, with updates available on the "2FIRSTS APP." Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
